Tuesday, September 17

Healthcare

Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity

08/29/20241 Min Read

3year exclusivity FDA injunction Liquidia preliminary requests Tyvaso

Previous ArticleUS House committee sends warning letters to CVS, Cigna, UnitedHealth

Next Article Virax stock rallies 22% on mpox detection kit deal